Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2025-03-17 00:00:00 ET · period of report 2025-03-13 · accession 0001628280-25-013141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-17 | 2025-03-14 | MYGN | Raha Samraat S. | COO | F - Tax | $10.07 | -7,649 | 481.2K | -2% | -$77.0K | |
| 2025-03-17 | 2025-03-13 | MYGN | Raha Samraat S. | COO | A - Grant | $0.00 | +216.5K | 488.9K | +79% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-14 | F | D | 7,649 | $10.07 | 481,240 | D | — | — | (F2) Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025. |
| 2 | Common | Common Stock | 2025-03-13 | A | A | 216,495 | $0.00 | 488,889 | D | — | — | (F1) Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. |